MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in ABSI — Absci Corp

CIK 1705339 CAUSEWAY BAY, K3

Position in ABSI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$931,963

+$685,186 QoQ

Shares Held

80,411

-2.2% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#87

of 195 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $436,102,859 across 286 Biotechnology names. ABSI ranks #90 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	150,692	$74,853,236
2	REGN	Regeneron Pharmaceuticals, Inc.	59,595	$37,159,864
3	ALNY	Alnylam Pharmaceuticals, Inc.	63,265	$19,044,662
4	RPRX	Royalty Pharma plc	259,390	$14,543,997
5	INCY	Incyte Corp	83,084	$9,418,401
6	PRAX	Praxis Precision Medicines, Inc.	27,185	$9,101,265
7	MRNA	Moderna, Inc.	106,564	$7,462,676
8	CRSP	CRISPR Therapeutics AG	122,658	$6,689,766

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$931,963	80,411	-2.2%	Shares	Defined	2026-08-14
2026-03-31	$246,777	82,259	+9.7%	Shares	Defined	2026-05-15
2025-12-31	$261,634	74,967	+22.7%	Shares	Defined	2026-02-17
2025-09-30	$185,765	61,107	+2.3%	Shares	Defined	2025-11-14
2025-06-30	$153,547	59,746	+24.9%	Shares	Defined	2025-08-14
2025-03-31	$120,048	47,828	+4.4%	Shares	Defined	2025-05-15
2024-12-31	$119,996	45,800	+4.5%	Shares	Defined	2025-02-14
2024-09-30	$167,407	43,824	—	Shares	Defined	2024-11-14
No filing history on record for this holder in this stock.